A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)

Peer Review reports

Original Submission
27 Feb 2020	Submitted	Original manuscript
27 Mar 2020	Reviewed	Reviewer Report - Edyta Borkowska
29 Mar 2020	Reviewed	Reviewer Report - Gregory Papagregoriou
15 Apr 2020	Author responded	Author comments - Jean-Pierre ROPERCH
22 Apr 2020	Reviewed	Reviewer Report - Edyta Borkowska
3 May 2020	Reviewed	Reviewer Report - Gregory Papagregoriou
4 May 2020	Author responded	Author comments - Jean-Pierre ROPERCH
Resubmission - Version 2
15 Apr 2020	Submitted	Manuscript version 2
11 May 2020	Author responded	Author comments - Jean-Pierre ROPERCH
Resubmission - Version 3
11 May 2020	Submitted	Manuscript version 3
13 May 2020	Author responded	Author comments - Jean-Pierre ROPERCH
Resubmission - Version 4
13 May 2020	Submitted	Manuscript version 4
Publishing
14 May 2020	Editorially accepted
24 May 2020	Article published	10.1186/s12881-020-01050-w

Back to article page